staurosporine has been researched along with Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allonca, E; Alvarez-Fernandez, C; Astudillo, A; Braña, A; Costales, P; Estupiñan, O; Fernandez-Garcia, MT; Fernandez-Nevado, L; Hermosilla, MA; Menendez, ST; Moris, F; Oro, P; Perez-Escuredo, J; Rey, V; Rodriguez, A; Rodriguez, R; Santos, L; Tornin, J | 1 |
Jansen, B; Maierhofer, H; Monia, BP; Pehamberger, H; Selzer, E; Skvara, H; Thallinger, C; Wacheck, V; Wolschek, MF | 1 |
Fujikawa-Yamamoto, K; Ikeda, T; Murano, H; Ohdoi, C; Wang, S; Yamagishi, H | 1 |
3 other study(ies) available for staurosporine and Sarcoma
Article | Year |
---|---|
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Carbazoles; Doxorubicin; Drug Synergism; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Protein Kinase Inhibitors; Sarcoma; Signal Transduction; Staurosporine; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neoplasm Transplantation; Oligonucleotides; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Sarcoma; Staurosporine; Time Factors | 2004 |
Establishment of a tetraploid Meth-A cell line through polyploidization by demecolcine but not by staurosporine, K-252A and paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Count; Cell Cycle; Cell Division; Demecolcine; DNA; Enzyme Inhibitors; Flow Cytometry; Indole Alkaloids; Karyotyping; Mice; Paclitaxel; Ploidies; Sarcoma; Staurosporine; Tumor Cells, Cultured | 2001 |